Cite
Primary tumour side as a driver for treatment choice in RAS wild-type metastatic colorectal cancer patients: a systematic review and pooled analysis of randomised trials.
MLA
Rossini, Daniele, et al. “Primary Tumour Side as a Driver for Treatment Choice in RAS Wild-Type Metastatic Colorectal Cancer Patients: A Systematic Review and Pooled Analysis of Randomised Trials.” European Journal of Cancer (Oxford, England : 1990), vol. 184, May 2023, pp. 106–16. EBSCOhost, https://doi.org/10.1016/j.ejca.2023.02.006.
APA
Rossini, D., Boccaccino, A., Carullo, M., Antoniotti, C., Dima, G., Ciracì, P., Marmorino, F., Moretto, R., Masi, G., & Cremolini, C. (2023). Primary tumour side as a driver for treatment choice in RAS wild-type metastatic colorectal cancer patients: a systematic review and pooled analysis of randomised trials. European Journal of Cancer (Oxford, England : 1990), 184, 106–116. https://doi.org/10.1016/j.ejca.2023.02.006
Chicago
Rossini, Daniele, Alessandra Boccaccino, Martina Carullo, Carlotta Antoniotti, Giovanni Dima, Paolo Ciracì, Federica Marmorino, Roberto Moretto, Gianluca Masi, and Chiara Cremolini. 2023. “Primary Tumour Side as a Driver for Treatment Choice in RAS Wild-Type Metastatic Colorectal Cancer Patients: A Systematic Review and Pooled Analysis of Randomised Trials.” European Journal of Cancer (Oxford, England : 1990) 184 (May): 106–16. doi:10.1016/j.ejca.2023.02.006.